Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial

The combination of bendamustine (B) and paclitaxel (P) as anthracycline-free treatment option in patients with advanced breast cancer has been evaluated in the previous RiTa I trial. The regimen of weekly B 70 mg/m(2) and P 90 mg/m(2) with a pause every 4th week was established as an effective regim...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Loibl, Sibylle, Doering, Gabriele, Müller, Lothar, Grote-Metke, Albert, Müller, Roberto, Tomé, Oliver, Wiest, Wolfgang, Maisch, Andrea, Nekljudova, Valentina, von Minckwitz, Gunter
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger GmbH 2011
Témata:
Original Article · Originalarbeit
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290015/
https://ncbi.nlm.nih.gov/pubmed/22419900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000335199
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky